Literature DB >> 5458179

Hemodynamic changes in long-term diuretic therapy of essential hypertension. A comparative study of chlorthalidone, polythiazide and hydrochlorothiazide.

P Lund-Johansen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5458179     DOI: 10.1111/j.0954-6820.1970.tb02977.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  13 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 3.  Small artery remodelling in hypertension: causes, consequences and therapeutic implications.

Authors:  Michael J Mulvany
Journal:  Med Biol Eng Comput       Date:  2008-05       Impact factor: 2.602

Review 4.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 5.  Diuretics. II. Clinical considerations.

Authors:  J L Anderton; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

6.  Clinical efficacy of fixed combinations of saluretic agents and potassium in sustained release form for the treatment of arterial hypertension.

Authors:  A Jäättelä
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

Review 7.  Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.

Authors:  M J Kendall
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

8.  A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; F H Schuurman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

10.  Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide.

Authors:  K Valmin; T Hansen
Journal:  Eur J Clin Pharmacol       Date:  1975-08-14       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.